confusing the news about Avandia and Actos
Some people are confusing the news about Avandia and Actos.
Avandia products will all but disappear...due to cardiac concerns.
After November 18th, prescribers and patients will have to be enrolled in the Avandia-Rosiglitazone Medicines Access Program to prescribe or get rosiglitazone.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: PA includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote